"Antibodies, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
Descriptor ID |
D000907
|
MeSH Number(s) |
D12.776.124.486.485.114.107 D12.776.124.790.651.114.125 D12.776.377.715.548.114.125
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Bacterial".
This graph shows the total number of publications written about "Antibodies, Bacterial" by people in this website by year, and whether "Antibodies, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 3 | 4 |
1996 | 5 | 4 | 9 |
1997 | 5 | 2 | 7 |
1998 | 1 | 5 | 6 |
1999 | 5 | 7 | 12 |
2000 | 1 | 9 | 10 |
2001 | 1 | 3 | 4 |
2002 | 4 | 7 | 11 |
2003 | 6 | 3 | 9 |
2004 | 7 | 4 | 11 |
2005 | 2 | 7 | 9 |
2006 | 6 | 5 | 11 |
2007 | 3 | 3 | 6 |
2008 | 5 | 8 | 13 |
2009 | 5 | 2 | 7 |
2010 | 5 | 4 | 9 |
2011 | 7 | 3 | 10 |
2012 | 3 | 7 | 10 |
2013 | 1 | 10 | 11 |
2014 | 4 | 3 | 7 |
2015 | 5 | 5 | 10 |
2016 | 2 | 4 | 6 |
2017 | 5 | 2 | 7 |
2018 | 4 | 1 | 5 |
2019 | 5 | 1 | 6 |
2020 | 2 | 1 | 3 |
2021 | 1 | 3 | 4 |
2022 | 0 | 3 | 3 |
2023 | 0 | 3 | 3 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Bacterial" by people in Profiles.
-
The efficacy of egg albumin nanoparticles adjuvanted Clostridium perfringens type D toxoid vaccine in rabbits. Braz J Microbiol. 2025 Mar; 56(1):665-674.
-
Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 22; 73(7):149-151.
-
PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):137-147.
-
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clin Infect Dis. 2023 10 13; 77(8):1102-1110.
-
Maternal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccination During Pregnancy: Impact on Infant Anti-Pertussis Antibody Concentrations by Maternal Pertussis Priming Series. Clin Infect Dis. 2023 02 08; 76(3):e1087-e1093.
-
Higher In Vivo Fecal Concentrations of Clostridioides difficile Toxins A and B in Patients With North American Pulsed-Field Gel Electrophoresis Type 1/Ribotype 027 Strain Infection. Clin Infect Dis. 2022 11 30; 75(11):2019-2022.
-
Human Monoclonal Antibodies to Escherichia coli Outer Membrane Protein A Porin Domain Cause Aggregation but Do Not Alter In Vivo Bacterial Burdens in a Murine Sepsis Model. Infect Immun. 2022 06 16; 90(6):e0017622.
-
Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti-Helicobacter pylori IgG Titers. Gastroenterology. 2022 05; 162(6):1705-1715.
-
The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis. Vaccine. 2022 01 24; 40(3):450-458.
-
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis. Vaccine. 2021 10 22; 39(44):6545-6552.